Johnm Oldham News Today : Breaking News, Live Updates & Top Stories | Vimarsana

From the prospect of semaglutide and MDMA for substance use disorder to evolving research around personality disorders and OCD, here are 5 key topics from the annual psychiatric meeting.

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions. However, many challenges remain in defining their clinical benefits and overcoming the complex regulatory obstacles to their use. The September issue of Journal of Psychiatric Practice presents a research review and update on therapeutic use of psychedelics – focusing on the use of psilocybin for treatment of depression. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions. However, many challenges remain in defining their clinical benefits and overcoming the complex regulatory obstacles to their use. The September issue of Journal of Psychiatric Practice presents a research review and update on therapeutic use of psychedelics – focusing on the use of psilocybin for treatment of depression. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.

Combining a form of individual and group therapy that focuses on experiential approaches is effective in reducing borderline personality disorder symptoms, new research suggests.

Early interventions that focus on clinical case management and psychiatric care are effective in young individuals with borderline personality disorder, new research suggests.